https://welltower.com/business-and-transaction-update
Natera Reports Centers For Medicare & Medicaid Services Granted Advanced Diagnostic Lab Test Status For Its Signatera Molecular Residual Disease Test
Natera,Inc. (NASDAQ:NTRA), a pioneer and global leader in cell-free DNA testing, today announced that the Centers for Medicare & Medicaid Services (CMS) has granted ADLT status for the Signatera molecular residual
